SERPING1 and hereditary angioedema: Clearance of radiolabeled C1 inhibitor appears to support this hypothesis,[27] although pharmacokinetic analyses of infused C1 inhibitor concentrates have not confirmed the evidence of more rapid turnover of C1 inhibitor in HAE patients.